Madison, Wisconsin
Novelos Therapeutics is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar’s novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs), with radioisotopes that destroy malignant cells. Cellectar’s products’ unique mechanism of action is based on selective accumulation and retention in malignant tumors and not normal cells.
View Website